Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy (ADT), yet many patients ...
May 31, 2024
0
0
Combining genomic analyses with information about clinical outcomes is a highly promising strategy to understanding prostate cancer and its treatment. Researchers say it could change how the disease is predicted and make ...
Jun 26, 2024
0
14
For a large percentage of men with prostate cancer, the tumor may be so slow-growing that doctors advise a "watch-and-wait" approach instead of active treatment.
May 30, 2024
0
8
Two genes working in tandem play a critical role in shaping the identity and behavior of prostate cancer cells and their response to treatment, UT Southwestern Medical Center researchers report.
Jun 5, 2024
0
0
Treatment resistance caused by cancer cell plasticity constitutes a major challenge in the treatment of prostate cancer. A recent study from the University of Eastern Finland Institute of Biomedicine published in Nucleic ...
Jun 3, 2024
0
1
A new research perspective titled "Starving cancer cells to enhance DNA damage and immunotherapy response" has been published in Oncotarget.
Jun 26, 2024
0
0
Fibroblast activation protein (FAP)-targeted radioligand therapy is safe and effective for treating patients with progressive metastatic tumors, specifically advanced sarcomas, according to research presented at the 2024 ...
Jun 10, 2024
0
0
A study of pre-COVID-19 health data has found that Australians over 70 are living longer, but their impact on the health care industry is increasing, according to research by the University of Adelaide.
Jun 12, 2024
0
0
From an economic perspective, first-line prostate-specific antigen (PSA) testing is favored over biparametric magnetic resonance imaging (bpMRI) for prostate cancer screening, mainly due to false-positive results and overdiagnosis, ...
Jun 4, 2024
0
0
Some women who experience menopause early—before age 40—have an increased risk of developing breast and ovarian cancer, according to research being presented at ENDO 2024, the Endocrine Society's annual meeting in Boston, ...
Jun 3, 2024
0
0
